Literature DB >> 28740653

Diagnosing and treating contrast-induced acute kidney injury in 2017.

Vikram Raje1,2, George Feldman1,2, Ion S Jovin1,2.   

Abstract

Entities:  

Year:  2017        PMID： 28740653      PMCID： PMC5506171          DOI： 10.21037/jtd.2017.05.58

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  10 in total

1.  Effects of Intra-Arterial and Intravenous Iso-Osmolar Contrast Medium (Iodixanol) on the Risk of Contrast-Induced Acute Kidney Injury: A Meta-Analysis.

Authors:  Peter A McCullough; Jeremiah R Brown
Journal:  Cardiorenal Med       Date:  2011-10-04       Impact factor: 2.041

Review 2.  Nephrotoxicity of contrast media.

Authors:  A S Berns
Journal:  Kidney Int       Date:  1989-10       Impact factor: 10.612

Review 3.  Review and evaluation of methods for computing confidence intervals for the ratio of two proportions and considerations for non-inferiority clinical trials.

Authors:  Rebekkah S Dann; Gary G Koch
Journal:  J Biopharm Stat       Date:  2005       Impact factor: 1.051

4.  Volume expansion and contrast-induced acute kidney injury.

Authors:  Peter A McCullough; Jun Zhang; Claudio Ronco
Journal:  Lancet       Date:  2017-02-21       Impact factor: 79.321

5.  A Comparison of Traditional and Novel Definitions (RIFLE, AKIN, and KDIGO) of Acute Kidney Injury for the Prediction of Outcomes in Acute Decompensated Heart Failure.

Authors:  Andrew K Roy; Catherine Mc Gorrian; Cecelia Treacy; Edel Kavanaugh; Alice Brennan; Niall G Mahon; Patrick T Murray
Journal:  Cardiorenal Med       Date:  2013-02-26       Impact factor: 2.041

6.  Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty.

Authors:  Christian Mueller; Gerd Buerkle; Heinz J Buettner; Jens Petersen; André P Perruchoud; Urs Eriksson; Stephan Marsch; Helmut Roskamm
Journal:  Arch Intern Med       Date:  2002-02-11

7.  Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.

Authors:  Estelle C Nijssen; Roger J Rennenberg; Patty J Nelemans; Brigitte A Essers; Marga M Janssen; Marja A Vermeeren; Vincent van Ommen; Joachim E Wildberger
Journal:  Lancet       Date:  2017-02-21       Impact factor: 79.321

8.  Hospital-acquired renal insufficiency.

Authors:  Kevin Nash; Abdul Hafeez; Susan Hou
Journal:  Am J Kidney Dis       Date:  2002-05       Impact factor: 8.860

9.  A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.

Authors:  M A Stevens; P A McCullough; K J Tobin; J P Speck; D C Westveer; D A Guido-Allen; G C Timmis; W W O'Neill
Journal:  J Am Coll Cardiol       Date:  1999-02       Impact factor: 24.094

Review 10.  Prevention of Contrast-Induced Acute Kidney Injury: an Update.

Authors:  George Chalikias; Ioannis Drosos; Dimitrios N Tziakas
Journal:  Cardiovasc Drugs Ther       Date:  2016-10       Impact factor: 3.727
  10 in total
  1 in total

1.  Low free triiodothyronine is associated with contrast-induced acute kidney injury and long-term outcome in elderly patients who underwent percutaneous coronary intervention.

Authors:  Chunjin Lin; Kaiyang Lin; Yansong Guo; Zhebin You; Weiping Zheng; Fan Lin; Tailin Guo; Pengli Zhu
Journal:  Anatol J Cardiol       Date:  2019-02       Impact factor: 1.596
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.